Cargando…

Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome

INTRODUCTION AND HYPOTHESIS: Intravesically administered lidocaine is used in patients with bladder pain syndrome (BPS) to test the hypothesis that symptoms have a peripheral versus central mechanism. METHODS: A cross-sectional study of 24 female patients with BPS was performed. The Central Sensitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Offiah, Ifeoma, Dilloughery, Elaine, McMahon, Stephen B., O’Reilly, Barry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647211/
https://www.ncbi.nlm.nih.gov/pubmed/30874834
http://dx.doi.org/10.1007/s00192-019-03892-2
_version_ 1783437681220386816
author Offiah, Ifeoma
Dilloughery, Elaine
McMahon, Stephen B.
O’Reilly, Barry A.
author_facet Offiah, Ifeoma
Dilloughery, Elaine
McMahon, Stephen B.
O’Reilly, Barry A.
author_sort Offiah, Ifeoma
collection PubMed
description INTRODUCTION AND HYPOTHESIS: Intravesically administered lidocaine is used in patients with bladder pain syndrome (BPS) to test the hypothesis that symptoms have a peripheral versus central mechanism. METHODS: A cross-sectional study of 24 female patients with BPS was performed. The Central Sensitisation Inventory (CSI) and Kings Health Questionnaire (KHQ) were completed. Urodynamic assessment was undertaken. Women were asked to report their pain using a numeric rating scale at cystometric capacity and post void. Participants then received an intravesical instillation of either 20 ml of 2% alkalinised lidocaine (n = 16) or 20 ml of normal saline (n = 8). These solutions were allowed to remain in situ for 20 min and pain score repeated. Urodynamics was repeated. RESULTS: There was a statistically significant volume increase following lidocaine treatment: maximal cystometric capacity (MCC) 192–261 ml post lidocaine (p = 0.005.) In contrast, there was no significant difference in the saline controls: MCC 190–183 ml (p = 0.879.) Individual analysis revealed five of 16 lidocaine participants did not respond to lidocaine. These five reported a significantly worse quality of life (QoL) than lidocaine responders and had a tendency towards central sensitivity syndromes. CONCLUSION: Lidocaine significantly improved MCC in 11/16 participants in this study. These patients appear to have peripherally mediated disease. However, the failure of response to treatment in five participants, as well as their tendency towards central sensitivity syndromes, implies that in this subgroup, a peripheral drive from the bladder is not critical to their pain, suggesting central nervous system (CNS) pathology. This simple and safe test could be used to stratify patients for research or therapeutic trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00192-019-03892-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6647211
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-66472112019-08-06 Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome Offiah, Ifeoma Dilloughery, Elaine McMahon, Stephen B. O’Reilly, Barry A. Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: Intravesically administered lidocaine is used in patients with bladder pain syndrome (BPS) to test the hypothesis that symptoms have a peripheral versus central mechanism. METHODS: A cross-sectional study of 24 female patients with BPS was performed. The Central Sensitisation Inventory (CSI) and Kings Health Questionnaire (KHQ) were completed. Urodynamic assessment was undertaken. Women were asked to report their pain using a numeric rating scale at cystometric capacity and post void. Participants then received an intravesical instillation of either 20 ml of 2% alkalinised lidocaine (n = 16) or 20 ml of normal saline (n = 8). These solutions were allowed to remain in situ for 20 min and pain score repeated. Urodynamics was repeated. RESULTS: There was a statistically significant volume increase following lidocaine treatment: maximal cystometric capacity (MCC) 192–261 ml post lidocaine (p = 0.005.) In contrast, there was no significant difference in the saline controls: MCC 190–183 ml (p = 0.879.) Individual analysis revealed five of 16 lidocaine participants did not respond to lidocaine. These five reported a significantly worse quality of life (QoL) than lidocaine responders and had a tendency towards central sensitivity syndromes. CONCLUSION: Lidocaine significantly improved MCC in 11/16 participants in this study. These patients appear to have peripherally mediated disease. However, the failure of response to treatment in five participants, as well as their tendency towards central sensitivity syndromes, implies that in this subgroup, a peripheral drive from the bladder is not critical to their pain, suggesting central nervous system (CNS) pathology. This simple and safe test could be used to stratify patients for research or therapeutic trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00192-019-03892-2) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-03-14 2019 /pmc/articles/PMC6647211/ /pubmed/30874834 http://dx.doi.org/10.1007/s00192-019-03892-2 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Offiah, Ifeoma
Dilloughery, Elaine
McMahon, Stephen B.
O’Reilly, Barry A.
Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
title Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
title_full Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
title_fullStr Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
title_full_unstemmed Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
title_short Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
title_sort prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647211/
https://www.ncbi.nlm.nih.gov/pubmed/30874834
http://dx.doi.org/10.1007/s00192-019-03892-2
work_keys_str_mv AT offiahifeoma prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome
AT dillougheryelaine prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome
AT mcmahonstephenb prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome
AT oreillybarrya prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome